
A to Z: Drugs in Highlight: K is for KALYDECO®
News
A to Z Feature
13/02/2025
This series continues to explore the fascinating world of pharmaceuticals. KALYDECO® (from Vertex Pharmaceutical Limited) uses ivacaftor for treating cystic fibrosis in people with certain mutations in the gene for a protein called cystic fibrosis transmembrane conductance regulator (CFTR).
Read more